Get a glimpse into our company and investor data—powered by the PitchBook Platform
Owner and operator of a biotechnology company. The company is focused on developing anti-cancer drugs for the treatment of brain cancer by utilizing molecular techniques.
You’re viewing a free company profile from the PitchBook Platform. To explore AngioClast’s full profile, request a free trial.
1 Former Executive
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.